These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25744740)

  • 21. Long-term results of BVS implantation: a focus on safety and efficacy of the bioresorbable technology.
    DEN Dekker WK; VAN Geuns RJ; Diletti R
    Minerva Cardioangiol; 2016 Aug; 64(4):462-72. PubMed ID: 27175976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-year results of ST-segment elevation myocardial infarction patients treated with a prespecified bioresorbable vascular scaffold implantation strategy: bVS STEMI STRATEGY-IT long-term.
    Moscarella E; Campo G; Leoncini M; Geraci S; Nicolini E; Cortese B; Loi B; Guiducci V; Saccà S; Varricchio A; Vicinelli P; De Candia G; Silvestro A; Calabrò P; Brugaletta S; Latib A; Tespili M; Ielasi A
    J Cardiovasc Med (Hagerstown); 2022 Apr; 23(4):278-280. PubMed ID: 35287160
    [No Abstract]   [Full Text] [Related]  

  • 23. [What is the place of bioresorbable vascular scaffolds in setting of ST-segment elevation myocardial infarction?].
    Lattuca B; Schmutz L; Ledermann B; Cornillet L; Messner-Pellenc P; Leclercq F; Cayla G
    Ann Cardiol Angeiol (Paris); 2015 Dec; 64(6):499-504. PubMed ID: 26482633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of early clinical outcomes between ABSORB bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world population.
    Costopoulos C; Latib A; Naganuma T; Miyazaki T; Sato K; Figini F; Sticchi A; Carlino M; Chieffo A; Montorfano M; Colombo A
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):E10-5. PubMed ID: 24909303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Letter regarding "Hybrid ABSORB bioresorbable vascular scaffold and drug eluting stent or hybrid BVS-DES percutaneous coronary intervention: Method and rationale for hybrid overlapping PCI".
    Granata F; Moscarella E; Varricchio A
    Int J Cardiol; 2015 Jul; 190():7-8. PubMed ID: 25912107
    [No Abstract]   [Full Text] [Related]  

  • 26. Imaging and functional assessment of bioresorbable scaffolds.
    Pighi M; Tanguay JF; L'allier PL
    Minerva Cardioangiol; 2016 Aug; 64(4):442-61. PubMed ID: 27195663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials.
    Muramatsu T; Onuma Y; van Geuns RJ; Chevalier B; Patel TM; Seth A; Diletti R; García-García HM; Dorange CC; Veldhof S; Cheong WF; Ozaki Y; Whitbourn R; Bartorelli A; Stone GW; Abizaid A; Serruys PW; ; ; ; ; ;
    JACC Cardiovasc Interv; 2014 May; 7(5):482-93. PubMed ID: 24746650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioresorbable Vascular Scaffolds　- Are We Facing a Time of Crisis or One of Breakthrough?
    Kang J; Han JK; Yang HM; Park KW; Kang HJ; Koo BK; Kim HS
    Circ J; 2017 Jul; 81(8):1065-1074. PubMed ID: 28680011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Absorb bioresorbable scaffold implantation technique on post-procedural quantitative coronary angiographic endpoints in ST-elevation myocardial infarction: a sub-analysis of the BVS STEMI STRATEGY-IT study.
    Hioki H; Brugaletta S; Ishida K; Campo G; Biscaglia S; Ortega-Paz L; Cortese B; Varricchio A; Latib A; Sabaté M; Tespili M; Ielasi A
    EuroIntervention; 2019 May; 15(1):108-115. PubMed ID: 30398966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The BVS concept. From the chemical structure to the vascular biology: the bases for a change in interventional cardiology.
    Tarantini G; Masiero G; Granada JF; Rapoza RJ
    Minerva Cardioangiol; 2016 Aug; 64(4):419-41. PubMed ID: 27078631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioresorbable vascular scaffolds: design, clinical trials, and current applications.
    Devito F; Zito A; Dachille A; Carbonara R; Giardinelli F; Bulzis G; Navarese EP; Scicchitano P; Gaglione A; Masi F; Ciccone MM
    Coron Artery Dis; 2016 Mar; 27(2):151-8. PubMed ID: 26717005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Case of Subacute Bioresorbable Vascular Scaffold Thrombosis, What was Wrong?
    Abualnaja SA; Alrammah HM; Alsaif BA; Almulla MO; Alzahrani BA
    Am J Case Rep; 2017 Dec; 18():1343-1346. PubMed ID: 29247157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The absorb bioresorbable vascular scaffold in coronary bifurcations: insights from bench testing.
    Džavík V; Colombo A
    JACC Cardiovasc Interv; 2014 Jan; 7(1):81-8. PubMed ID: 24332424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.
    Wang CH; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Jin XF; Zeng Y; Liu ZY; Xie HZ; Yang M
    Chin Med J (Engl); 2012 Aug; 125(16):2803-6. PubMed ID: 22932070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry.
    Abe D; Sato A; Hoshi T; Maruta S; Misaki M; Kakefuda Y; Watabe H; Hiraya D; Sakai S; Kawabe M; Takeyasu N; Aonuma K
    J Cardiol; 2014 Nov; 64(5):377-83. PubMed ID: 24685689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absorb bioresorbable vascular scaffold: What have we learned after 5 years of clinical experience?
    Caiazzo G; Kilic ID; Fabris E; Serdoz R; Mattesini A; Foin N; De Rosa S; Indolfi C; Di Mario C
    Int J Cardiol; 2015 Dec; 201():129-36. PubMed ID: 26298354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioresorbable Vascular Scaffold Implantation: To Whom and How?
    Sabaté M
    JACC Cardiovasc Interv; 2017 Sep; 10(18):1865-1866. PubMed ID: 28935078
    [No Abstract]   [Full Text] [Related]  

  • 38. Two-year follow-up after bioresorbable vascular scaffold implantation in STEMI patients - Results from PRAGUE-19 study.
    Toušek P; Kočka V; Malý M; Kozel M; Robert P; Hajšl M; Jarkovský J; Widimský P
    Int J Cardiol; 2016 Apr; 209():20-1. PubMed ID: 26878467
    [No Abstract]   [Full Text] [Related]  

  • 39. Stent thrombosis with second-generation drug-eluting stents compared with bare-metal stents: network meta-analysis of primary percutaneous coronary intervention trials in ST-segment–elevation myocardial infarction [corrected].
    Philip F; Agarwal S; Bunte MC; Goel SS; Tuzcu EM; Ellis S; Kapadia SR
    Circ Cardiovasc Interv; 2014 Feb; 7(1):49-61. PubMed ID: 24280964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contemporary Management of ST-Elevation Myocardial Infarction.
    Dind A; Allahwala U; Asrress KN; Jolly SS; Bhindi R
    Heart Lung Circ; 2017 Feb; 26(2):114-121. PubMed ID: 27617370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.